What is Aldeyra The (ALDX) stock price today?

Aldeyra The (ALDX) currently trades at $1.52 per share. The stock has a market capitalization of $93.28M and a P/E ratio of —x.

Is ALDX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Aldeyra The has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -4.78.

Is Aldeyra The financially healthy?

Aldeyra The's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -4.78 places it in the distress.

ALDX

Aldeyra The

NASDAQ: ALDX · HEALTHCARE · BIOTECHNOLOGY

$1.52

+1.33% today

Updated 2026-04-30

Market cap

$93.28M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.56

Dividend yield

—

52W range

$1 – $6

Volume

3.6M

Market cap

$93.28M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.56

Dividend yield

—

52W range

$1 – $6

Volume

3.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.5

Quality

C+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-4.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$7.50

+393.42%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.32x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -4.78 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-5.30M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-62.02M	$-37.54M	$-55.85M	$-33.85M	$-6.46M
EPS	—	—	—	—	$-0.56
Free cash flow	$-56.65M	$-30.33M	$-43.21M	$-33.35T	$-5.30M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ALDX	$93.28M	25	4.3	3.0	5.0	5.5	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Aldeyra The trades at $1.52. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -4.78, it sits in the distress.

Frequently asked questions

What is Aldeyra The's stock price?

Aldeyra The (ALDX) trades at $1.52.

Is Aldeyra The overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Aldeyra The (ALDX)?

The analyst target price is $7.50, representing +393.4% upside from the current price of $1.52.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-4.78 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.aldeyra.com

Quick metrics

P/S ratio—

ROE-58.70%

Beta1.33

50D MA$3.18

200D MA$4.67

Shares out0.06B

Float0.05B

Short ratio—

Avg volume3.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ALDX vs LLY →ALDX vs JNJ →ALDX vs ABBV →Stock screener →